Summer 2019 has come and gone, and your attention is set on fantasy football! That means it’s time for a quarterly update from NuVasive Clinical Services (NCS). Today we’re giving you the scoop on new tools for increasing OR efficiency and spotlighting how less invasive surgery changed the life of a NFL Hall of Fame running back. Hint: “The Bus”.
NuVasive recently announced the commercial launch of Pulse, an integrated technology platform to enable better spine surgery. In a single expandable platform, Pulse integrates multiple enabling technologies to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. These technologies include neuromonitoring, global alignment, rod bending, radiation reduction, imaging, navigation, robotics, smart tools and other applications. Learn more.
Welcoming a new biologic—Propel DBM Sponge
Propel DBM Sponge is a unique form of partially demineralized bone matrix, consisting of 100% cancellous bone with no carrier. It is engineered as a single piece of bone for handling and ease of use. Following hydration, Propel DBM Sponge is able to fill, compress, and conform to a variety of bony voids and accommodate difficult anatomy. It provides a natural osteoconductive scaffold and osteoinductive signaling properties to support new bone growth.1 Learn more.
After his life-changing XLIF procedure, Jerome ‘The Bus’ Bettis becomes a NuVasive brand ambassador.
Learn more about NuVasive’s porous titanium spine implant engineered for the TLIF procedure.
Sr. Neurophysiologist, Massachusetts North/New Hampshire.
“The best part of my job is having the ability to cultivate my voice and the voice of my patients, who are at times unable to appropriately advocate for themselves. I also love collaborating with hospital staff as they manage in-patient care, helping play a role in improving postoperative outcomes.“Hear more from the NCS team at #MeetTheNP.
|
|